Free Trial
TSE:AEZS

Aeterna Zentaris (AEZS) Stock Price, News & Analysis

Aeterna Zentaris logo

About Aeterna Zentaris Stock (TSE:AEZS)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
C$5.00
C$8.29
52-Week Range
N/A
Volume
1,232 shs
Average Volume
1,137 shs
Market Capitalization
C$25.37 million
P/E Ratio
N/A
Dividend Yield
2.79%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive AEZS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aeterna Zentaris and its competitors with MarketBeat's FREE daily newsletter.

AEZS Stock News Headlines

Closing Bell: Aeterna Zentaris Inc up on Monday (AEZS)
AEZS:CA Aeterna Zentaris Inc.
I was wrong about Trump
I made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.
Closing Bell: Aeterna Zentaris Inc flat on Friday (AEZS)
See More Headlines

AEZS Stock Analysis - Frequently Asked Questions

Shares of AEZS stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Aeterna Zentaris investors own include Meta Platforms (META), Novavax (NVAX), Verizon Communications (VZ), Western Uranium & Vanadium (WUC), Air Canada (AC), Affirm (AFRM) and AutoZone (AZO).

Industry, Sector and Symbol

Stock Exchange
TSE
Sector
Medical
Industry
Biotechnology
Sub-Industry
Pharmaceutical Products
Current Symbol
TSE:AEZS
CIK
N/A
Fax
N/A
Employees
20
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-C$18.05 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$2.37 million
Price / Cash Flow
0.46
Book Value
C$10.68 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
C$25.37 million
Optionable
Not Optionable
Beta
2.26
20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

This page (TSE:AEZS) was last updated on 7/8/2025 by MarketBeat.com Staff
From Our Partners